Legal & General Group
FRLN

Legal & General Group’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Legal & General Group’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,003
Closed -$51K – 3591
2021
Q3 		$51K Hold
1,003
– – ﹤0.01% 2968
2021
Q2 		$124K Buy
1,003
+131
+15% +$20.4K ﹤0.01% 2671
2021
Q1 		$168K Hold
872
– – ﹤0.01% 2490
2020
Q4 		$239K Buy
+872
New +$219K ﹤0.01% 2384

Other funds holding FRLN

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Legal & General Group's FRLN Position: Q4 2021 in Review

Legal & General Group sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q4 2021, closing a stake of 1,003 shares — an estimated $51K sold.

Legal & General Group first reported a position in FRLN in Q4 2020 and held it in 4 quarters. The position peaked at $239K in Q4 2020. 18 funds tracked by Wall St. Rank hold FRLN as of Q4 2021.

  • Legal & General Group reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Legal & General Group sold 1,003 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q4 2021, an estimated $51K.
  • Legal & General Group first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q4 2020 and held it in 4 quarters.
  • Legal & General Group's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $239K in Q4 2020.
  • 18 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q4 2021.

Based on Legal & General Group's 13F filing for Q4 2021, filed 14 Feb 2022.